News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
669,788 Results
Type
Article (53648)
Company Profile (381)
Press Release (615759)
Section
Business (188659)
Career Advice (2723)
Deals (34376)
Drug Delivery (117)
Drug Development (82130)
Employer Resources (169)
FDA (16638)
Job Trends (15500)
News (330660)
Policy (33108)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (6)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (10)
2024 Biotech Beach Standard (7)
2024 Genetown Digital (7)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (6)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (7)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2875)
Accelerated approval (3)
Adcomms (28)
Allergies (86)
Alliances (48274)
ALS (92)
Alzheimer's disease (1442)
Antibody-drug conjugate (ADC) (134)
Approvals (16609)
Artificial intelligence (256)
Autoimmune disease (21)
Automation (14)
Bankruptcy (347)
Best Places to Work (11871)
BIOSECURE Act (19)
Biosimilars (114)
Biotechnology (290)
Bladder cancer (65)
Brain cancer (28)
Breast cancer (267)
Cancer (2122)
Cardiovascular disease (186)
Career advice (2290)
Career pathing (32)
CAR-T (153)
Cell therapy (432)
Cervical cancer (20)
Clinical research (66428)
Collaboration (826)
Compensation (326)
Complete response letters (30)
COVID-19 (2826)
CRISPR (41)
C-suite (227)
Cystic fibrosis (105)
Data (1997)
Decentralized trials (2)
Denatured (27)
Depression (49)
Diabetes (269)
Diagnostics (6442)
Digital health (18)
Diversity (3)
Diversity, equity & inclusion (40)
Drug discovery (117)
Drug pricing (113)
Drug shortages (29)
Duchenne muscular dystrophy (92)
Earnings (71955)
Editorial (39)
Employer branding (22)
Employer resources (149)
Events (98168)
Executive appointments (670)
FDA (17792)
Featured Employer (49)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (726)
Gene editing (107)
Generative AI (24)
Gene therapy (312)
GLP-1 (794)
Government (4724)
Grass and pollen (5)
Guidances (48)
Healthcare (19368)
Huntington's disease (24)
IgA nephropathy (26)
Immunology and inflammation (128)
Indications (27)
Infectious disease (2974)
Inflammatory bowel disease (145)
Inflation Reduction Act (11)
Influenza (52)
Intellectual property (90)
Interviews (509)
IPO (15673)
IRA (45)
Job creations (4073)
Job search strategy (1916)
Kidney cancer (10)
Labor market (28)
Layoffs (522)
Leadership (20)
Legal (7562)
Liver cancer (76)
Lung cancer (309)
Lymphoma (138)
Machine learning (4)
Management (59)
Manufacturing (284)
MASH (65)
Medical device (13350)
Medtech (13355)
Mergers & acquisitions (19169)
Metabolic disorders (709)
Multiple sclerosis (77)
NASH (22)
Neurodegenerative disease (100)
Neuropsychiatric disorders (30)
Neuroscience (1974)
NextGen: Class of 2025 (6996)
Non-profit (4872)
Northern California (2347)
Now hiring (31)
Obesity (385)
Opinion (250)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (78)
Parkinson's disease (143)
Partnered (19)
Patents (209)
Patient recruitment (96)
Peanut (50)
People (56320)
Pharmaceutical (65)
Pharmacy benefit managers (20)
Phase I (20736)
Phase II (29110)
Phase III (22040)
Pipeline (1079)
Podcasts (89)
Policy (131)
Postmarket research (2614)
Preclinical (8538)
Press Release (64)
Prostate cancer (98)
Psychedelics (38)
Radiopharmaceuticals (254)
Rare diseases (395)
Real estate (5824)
Recruiting (70)
Regulatory (22915)
Reports (35)
Research institute (2544)
Resumes & cover letters (416)
Rett syndrome (3)
RNA editing (4)
RSV (47)
Schizophrenia (74)
Series A (129)
Series B (84)
Service/supplier (10)
Sickle cell disease (55)
Southern California (2109)
Special edition (18)
Spinal muscular atrophy (158)
Sponsored (27)
Startups (3692)
State (2)
Stomach cancer (15)
Supply chain (64)
The Weekly (60)
United States (20848)
Vaccines (764)
Venture capitalists (39)
Webinars (12)
Weight loss (276)
Women's health (32)
Worklife (18)
Date
Today (141)
Last 7 days (726)
Last 30 days (2798)
Last 365 days (33615)
2025 (8158)
2024 (35210)
2023 (39836)
2022 (50960)
2021 (55398)
2020 (54480)
2019 (47839)
2018 (36502)
2017 (33370)
2016 (32590)
2015 (37253)
2014 (29255)
2013 (24019)
2012 (25671)
2011 (26348)
2010 (23955)
Location
Africa (940)
Alabama (52)
Alaska (7)
Arizona (186)
Arkansas (14)
Asia (39702)
Australia (6841)
California (5497)
Canada (1767)
China (483)
Colorado (249)
Connecticut (255)
Delaware (130)
Europe (90839)
Florida (772)
Georgia (193)
Hawaii (1)
Idaho (59)
Illinois (516)
India (24)
Indiana (290)
Iowa (9)
Japan (139)
Kansas (102)
Kentucky (26)
Louisiana (8)
Maine (66)
Maryland (843)
Massachusetts (4036)
Michigan (210)
Minnesota (370)
Mississippi (2)
Missouri (79)
Montana (26)
Nebraska (25)
Nevada (49)
New Hampshire (68)
New Jersey (1516)
New Mexico (31)
New York (1552)
North Carolina (979)
North Dakota (8)
Northern California (2347)
Ohio (192)
Oklahoma (14)
Oregon (36)
Pennsylvania (1186)
Puerto Rico (9)
Rhode Island (25)
South America (1300)
South Carolina (19)
South Dakota (1)
Southern California (2109)
Tennessee (90)
Texas (773)
Utah (174)
Virginia (133)
Washington D.C. (60)
Washington State (514)
West Virginia (3)
Wisconsin (48)
669,788 Results for "oncoarendi therapeutics sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of its annual general meeting (AGM) of shareholders, which took place in Geneva today.
June 27, 2024
·
3 min read
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
RELIEF THERAPEUTICS Holding SA announces the results of the extraordinary general meeting of shareholders, which took place in Geneva , Friday, April 26, 2024.
April 26, 2024
·
4 min read
Press Releases
LimmaTech Vaccinates First Participants in Phase 1 Study of Staphylococcus aureus Vaccine Candidate LBT-SA7
February 17, 2025
·
4 min read
Press Releases
Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A
October 1, 2024
·
7 min read
Press Releases
Acquisition of Ovizio Imaging Systems SA
October 17, 2024
·
1 min read
Business
ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture
ExcellGene SA proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization based in the USA.
May 8, 2024
·
3 min read
Deals
Stryker completes acquisition of SERF SAS
Stryker (NYSE: SYK), a leading global medical technology company, announced today that it has completed the previously announced acquisition of SERF SAS, a France -based joint replacement company, from Menix.
March 21, 2024
·
4 min read
Press Releases
ChemoMetec makes offer to buy Ovizio Imaging Systems SA
September 23, 2024
·
1 min read
Inhalis Therapeutics SA Achieves Key Milestone with Patent Application Filing
Inhalis Therapeutics SA, a pioneering privately-held company specializing in advanced inhaled treatments for life-threatening diseases, proudly reveals a significant stride forward as it submits a new patent application on INHAL-101, its lead asset.
August 21, 2023
·
2 min read
Drug Development
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster
Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the results of a follow-up analysis of a Phase 3 study evaluating a booster dose of ARCT-154 , the world’s first approved self-amplifying messenger RNA (sa-mRNA) COVID-19 vaccine, compared to a conventional mRNA COVID-19 vaccine.
February 5, 2024
·
8 min read
1 of 66,979
Next
